METLIFE, INC.

(MET)
  Report
Delayed Nyse  -  05/20 04:00:01 pm EDT
62.05 USD   -0.54%
05/16METLIFE INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
05/16MetLife Declares Second Quarter 2022 Preferred Stock Dividends
BU
05/12MetLife Foundation Directs Corporate Art Funds to Underserved Creatives
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

MetLife in $3.5 Billion Longevity Reinsurance Deal

01/20/2022 | 02:03pm EDT

By Stephen Nakrosis


Metropolitan Tower Life Insurance Co. on Thursday said it completed a longevity reinsurance transaction involving an unnamed U.K. pension scheme, with Zurich Assurance Ltd., an independent U.K.-regulated insurer, acting as intermediary.

The deal will see Metropolitan Tower Life Insurance provide reinsurance for longevity risk associated with about $3.5 billion of pension liabilities, the company said.

Metropolitan Tower Life Insurance is a subsidiary of MetLife Inc.

The deal, which was completed in the fourth quarter of last year, is MetLife's first longevity swap of U.K. pension scheme liabilities, the company said.

Aon PLC acted as lead adviser to the scheme for the transaction, MetLife said.


Write to Stephen Nakrosis at stephen.nakrosis@wsj.com


(END) Dow Jones Newswires

01-20-22 1403ET

Stocks mentioned in the article
ChangeLast1st jan.
AON PLC -1.48% 262.71 Delayed Quote.-12.59%
METLIFE, INC. -0.54% 62.05 Delayed Quote.-0.70%
All news about METLIFE, INC.
05/16METLIFE INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
05/16MetLife Declares Second Quarter 2022 Preferred Stock Dividends
BU
05/12MetLife Foundation Directs Corporate Art Funds to Underserved Creatives
BU
05/11Zurich Insurance's 1Q Gross Written Premiums Rose
DJ
05/09METLIFE, INC. : Ex-dividend day for
FA
05/05METLIFE INC Management's Discussion and Analysis of Financial Condition and Results of..
AQ
05/05MetLife Earns 2022 ENERGY STAR® Partner of the Year ‘Sustained Excellence' Award
BU
05/05WALL STREET STOCK EXCHANGE : Another win for Powell
05/05TRANSCRIPT : MetLife, Inc., Q1 2022 Earnings Call, May 05, 2022
CI
05/05MARKETSCREENER'S WORLD PRESS REVIEW : May 5, 2022
More news
Analyst Recommendations on METLIFE, INC.
More recommendations
Financials (USD)
Sales 2022 68 299 M - -
Net income 2022 4 878 M - -
Net Debt 2022 - - -
P/E ratio 2022 10,8x
Yield 2022 3,20%
Capitalization 50 459 M 50 459 M -
Capi. / Sales 2022 0,74x
Capi. / Sales 2023 0,72x
Nbr of Employees -
Free-Float 56,5%
Chart METLIFE, INC.
Duration : Period :
MetLife, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends METLIFE, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 16
Last Close Price 62,05 $
Average target price 76,07 $
Spread / Average Target 22,6%
EPS Revisions
Managers and Directors
Michel A. Khalaf President, Chief Executive Officer & Director
John D. McCallion Chief Financial Officer, Treasurer & Executive VP
Robert Glenn Hubbard Chairman
Bill Pappas Executive VP & Head-Global Technology & Operations
Pawan Verma Chief Information Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
METLIFE, INC.-0.70%50 459
AXA-11.71%58 291
PRUDENTIAL FINANCIAL, INC.-8.81%37 013
AFLAC INCORPORATED-5.65%35 487
PRUDENTIAL PLC-21.07%34 329
MANULIFE FINANCIAL CORPORATION-6.97%33 622